STOCK TITAN

Angi Inc SEC Filings

ANGI Nasdaq

Welcome to our dedicated page for Angi SEC filings (Ticker: ANGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Angi Inc. reimagines how homeowners hire plumbers, roofers, and remodelers, so its disclosures dive deep into lead-generation economics, service margins, and marketplace safety measures. Looking for Angi SEC filings explained simply? Whether you need the full Angi annual report 10-K simplified or quick context on an Angi 8-K material events explained, Stock Titan brings every line item to the surface.

Our platform ingests each Angi quarterly earnings report 10-Q filing the moment it hits EDGAR, then delivers AI-powered summaries that translate segment revenue swings and cohort retention tables into plain English. Turn on instant alerts for Angi Form 4 insider transactions real-time and monitor Angi executive stock transactions Form 4 without refreshing EDGAR. You will also find the Angi proxy statement executive compensation decoded, so pay packages and performance targets are clear in minutes.

Investors use these insights to track Ads & Leads growth versus the on-demand Services segment, spot patterns in Angi insider trading Form 4 transactions, and benchmark marketing spend disclosed in 10-Qs. Every document, from amendments to Angi earnings report filing analysis, is indexed with keywords like understanding Angi SEC documents with AI to answer natural questions such as “How to read Angi’s 10-K?” Real-time updates, comprehensive coverage, and approachable explanations—Stock Titan turns dense filings into actionable clarity.

Filing
Rhea-AI Summary

Angi (ANGI) reported insider activity by its Chief Operating Officer on 10/15/2025. The officer acquired 10,000 shares of Class A Common Stock upon RSU conversion and disposed of 3,010 shares at $14.08. Following these transactions, directly held common shares were 20,156. Derivative holdings included 30,000 restricted stock units.

The figures reflect a 1-for-10 reverse stock split effective March 24, 2025. The filing also corrects prior administrative errors regarding vesting and date entries tied to RSUs granted on October 15, 2024, which vest in four equal annual installments beginning on the first anniversary of the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Angi Inc. (ANGI) Chief Growth Officer reported Form 4 activity on 10/15/2025 tied to restricted stock units. 10,000 shares of Class A Common Stock were acquired upon RSU vesting (code M), followed by a disposition of 4,701 shares to cover taxes at $14.08 per share (code F). After these transactions, the reporting person beneficially owned 9,272 shares directly.

The derivative table shows RSUs converting 1-for-1 into common stock and 30,000 RSUs remaining beneficially owned after the reported transactions. Amounts reflect Angi’s 1-for-10 reverse stock split effective March 24, 2025. The filing also corrects prior administrative errors regarding vesting and date fields in a previous submission.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Angi Inc. reported insider activity by Director Angela R. Hicks Bowman. On 10/15/2025, 2,500 restricted stock units converted into Class A shares (one-for-one), increasing her holdings. The company notes its 1-for-10 reverse stock split became effective on 3/24/2025, and amounts reflect this adjustment.

To cover taxes, 712 shares were withheld at $14.08. Following these transactions, she directly owned 27,390 Class A shares, with 7,500 RSUs remaining. The RSUs were part of a grant originally issued on 10/15/2024 that vests in four equal annual installments, subject to continued service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Kris Boon, Chief Product Officer of Angi Inc. (ANGI), received a grant of 72,500 restricted stock units on 09/17/2025 that convert to Class A common shares upon vesting. The award is reported as direct ownership of 72,500 shares following the grant. The RSUs vest in three installments: approximately 21% on March 1, 2027, 21% on March 1, 2028, and 59% on March 1, 2029, subject to continued service. The Form 4 was signed by an attorney-in-fact on 09/18/2025. Each RSU represents a contingent right to one share of Class A common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Glenn Orchard, Chief Growth Officer of Angi Inc. (ANGI), was granted 35,666 restricted stock units on 09/17/2025. Each unit represents a contingent right to receive one share of Class A common stock, and the award is recorded as directly beneficially owned at 35,666 shares following the grant. The RSUs vest in three tranches: approximately 16% on March 1, 2027, 16% on March 1, 2028, and 68% on March 1, 2029, subject to continued service, so the award will be fully vested on March 1, 2029. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 09/18/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Angi Inc. Chief Operating Officer Carson Bailey was granted 37,500 restricted stock units (RSUs) on 09/17/2025, each representing the right to receive one share of Class A common stock. The award vests in three installments: 20% on March 1, 2027, 20% on March 1, 2028, and 60% on March 1, 2029, subject to continued service. Following the reported transaction, Mr. Bailey beneficially owns 37,500 shares on a direct basis as reported. The Form 4 was signed by Shannon M. Shaw as attorney-in-fact on 09/18/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Shannon Shaw, Chief Legal Officer of Angi Inc. (ANGI), received a grant of 27,084 restricted stock units (RSUs) on 09/17/2025. Each RSU represents the right to one share of Class A common stock and will convert to shares upon vesting. The award vests in three tranches: approximately 29% on March 1, 2027, 29% on March 1, 2028, and 42% on March 1, 2029, contingent on continued service. Following the grant, Ms. Shaw beneficially owns 27,084 shares of Class A common stock on a direct basis. The RSUs have no exercise price and are reported as derivative securities tied to underlying common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Angi Inc. insider award reported: A director received 13,500 restricted stock units (RSUs) that each convert into one share of Class A common stock. The award vests in three installments—approximately 15%, 30% and 56%—on successive annual vesting dates beginning in 2027, and is scheduled to be fully vested by 2029, subject to continued service. The transaction was recorded as an acquisition and the reporting form was submitted by a single reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Angi Inc. (ANGI) reported a grant of 55,834 restricted stock units to Andrew Russakoff, the company's Chief Financial Officer, in a transaction dated 09/17/2025. Each unit represents a contingent right to one share of Class A Common Stock and the award carries a $0 purchase price.

The award vests in three installments: approximately 7% on March 1, 2027, 43% on March 1, 2028 and 49% on March 1, 2029, subject to continued service, so the award will be fully vested on March 1, 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Shannon Shaw, Chief Legal Officer of Angi Inc. (ANGI), reported insider transactions on 09/02/2025. On that date 3,554 restricted stock units vested and converted one-for-one into Class A common shares, increasing her beneficial ownership to 56,643 shares. The filing also shows a sale of 1,044 shares at $17.56 each, leaving 55,599 shares beneficially owned after the reported transactions. The RSUs were part of a 142,180-unit grant (pre-reverse split) that vests in four equal annual installments beginning one year after grant. The report is a routine Section 16 disclosure reflecting scheduled vesting and a market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Angi (ANGI)?

The current stock price of Angi (ANGI) is $13.38 as of October 17, 2025.

What is the market cap of Angi (ANGI)?

The market cap of Angi (ANGI) is approximately 599.9M.
Angi Inc

Nasdaq:ANGI

ANGI Rankings

ANGI Stock Data

599.95M
38.73M
9.71%
102.97%
13.95%
Internet Content & Information
Services-advertising
Link
United States
NEW YORK